/PRNewswire/ The American Brain Foundation is thrilled to announce the recipients of the 2022 Cure One, Cure Many Award for the early diagnosis of Lewy body.
Groundbreaking research award established to discover an accurate method of diagnosing Lewy body dementia biospace.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from biospace.com Daily Mail and Mail on Sunday newspapers.
Groundbreaking research award established to discover an accurate method of diagnosing Lewy body dementia
News provided by
Share this article
American Academy of Neurology to establish its 2022 Cure One, Cure Many Award: A research award for early diagnosis of Lewy body dementia. This $3 million, multi-year research award was created to improve the diagnosis of Lewy body dementia (LBD), which causes a progressive decline in cognitive function and is the second most common cause of neurodegenerative dementia, after Alzheimer s disease.
Currently, LBD can only be definitively diagnosed with a brain autopsy after death. As a result of a delay in diagnosis and misdiagnosis, people with LBD and their caregivers endure daily challenges and uncertainty.
Groundbreaking research award established to discover an accurate method of diagnosing Lewy body dementia prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.